S4. Hormone and metabolic modulators

The following hormone and metabolic modulators are prohibited:

1. Aromatase inhibitors including, but not limited to:

  • 4-Androstene-3,6,17 trione (6-oxo);
  • Aminoglutethimide;
  • Anastrozole;
  • Androsta-1,4,6-triene-3,17-dione (androstatrienedione);
  • Androsta-3,5-diene-7,17-dione (arimistane);
  • Exemestane;
  • Formestane;
  • Letrozole;
  • Testolactone.

2. Selective estrogen receptor modulators (SERMs) including, but not limited to:

  • Raloxifene;
  • Tamoxifen;
  • Toremifene.

3. Other anti-estrogenic substances including, but not limited to:

  • Clomiphene;
  • Cyclofenil;
  • Fulvestrant.

4. Agents modifying myostatin function(s) including, but not limited, to:myostatin inhibitors.

5. Metabolic modulators:

5.1 Activators of the AMP-activated protein kinase (AMPK), e.g. AICAR; and Peroxisome Proliferator Activated Receptor δ (PPARδ) agonists, e.g. GW 1516;

5.2 Insulins and insulin-mimetics;

5.3 Meldonium;

5.4 Trimetazidine.